Table 3.
Characteristic | Prepandemic: March 14, 2019, to March 14, 2020 (n=2714) | Pandemic steady-state: March 14, 2021, to March 14, 2022 (n=581) | P value | ||
Geography, n (%) |
|
|
.71 | ||
|
Northeast | 697 (25.68) | 136 (23.41) |
|
|
|
Midwest | 300 (11.05) | 64 (11.02) |
|
|
|
South | 770 (28.37) | 171 (29.43) |
|
|
|
West | 947 (34.89) | 210 (36.14) |
|
|
Funding round, n (%)a | <.001 | ||||
|
Seed | 586 (69) | 200 (86.6) |
|
|
|
Early stage | 173 (20) | 26 (11.3) |
|
|
|
Private equity | 11 (1.3) | 0 (0) |
|
|
|
IPOb | 16 (1.9) | 2 (0.9) |
|
|
|
M&Ac | 57 (6.7) | 3 (1.3) |
|
|
|
Late stage | 8 (0.9) | 0 (0) |
|
|
Total funding per year since founding (US $), mean (SD)d | 10,832,252 (45,669,417) | 14,348,739 (52,119,919) | .34 | ||
Number of founders, mean (SD)e | 1.75 (0.96) | 1.62 (0.88) | .02 |
aData available for 851 companies prepandemic and 231 companies in the pandemic stead state.
bIPO: initial public offering.
cM&A: mergers and acquisitions.
dData available for 901 companies prepandemic and 201 companies in the pandemic steady-state.
eData available for 1417 companies in prepandemic and 312 in the pandemic steady-state.